Anika Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Anika Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $7.66M, a 5.56% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.